February 1, 2019
Japan Tobacco on January 31 filed a new drug application in Japan for its ointment JAK inhibitor delgocitinib (development code: JTE-052) for the treatment of atopic dermatitis, the company and its group company Torii Pharmaceutical, a codeveloper, said the same...read more